SRC as a novel therapeutic target fot the treatment of triple negative breast cancer (TNBC)

被引：0
|
作者：
Walsh, S. [1 ]
Tryfonopoulos, D. [2 ,3 ]
Quinn, C. [4 ]
Flanagan, L. [4 ]
Pierce, A. [1 ]
McDermott, E. W. [1 ]
Evoy, D. [1 ]
O'Donovan, N. [2 ]
Crown, J. [2 ,3 ]
Duffy, M. J. [1 ,4 ]
机构：
[1] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland
[2] Dublin City Univ, NICB, Dublin 9, Ireland
[3] St Vincents Univ Hosp, Dept Med Oncol, Dublin 4, Ireland
[4] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2011年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Effects of Hsp90 inhibitors on triple negative breast cancer: BRCA1 as a therapeutic target for TNBC
    Ramamoorthy, Prabhu
    Rangarajan, Parthasarathy
    Tawfik, Ossama
    Anant, Shrikant
    Jensen, Roy A.
    CANCER RESEARCH, 2016, 76
  • [23] Potential therapeutic target for triple-negative breast cancer
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (08): : E330 - E330
  • [24] Immune checkpoints A therapeutic target in triple negative breast cancer
    Chawla, Akhil
    Philips, Anne V.
    Alatrash, Gheath
    Mittendorf, Elizabeth
    ONCOIMMUNOLOGY, 2014, 3 (04)
  • [25] A novel therapeutic approach for triple negative breast cancer
    Boopalan, Thiyagarajan
    Arumugam, Arunkumar
    Suman, Suman
    Das, Trinath P.
    Damodaran, Chendil
    Lakshmanaswamy, Rajkumar
    CANCER RESEARCH, 2012, 72
  • [26] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mohd Mustafa
    Kashif Abbas
    Mudassir Alam
    Waleem Ahmad
    Nazura Moinuddin
    Shahid Ali Usmani
    Safia Siddiqui
    Molecular and Cellular Biochemistry, 2024, 479 : 895 - 913
  • [27] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mustafa, Mohd
    Abbas, Kashif
    Alam, Mudassir
    Ahmad, Waleem
    Moinuddin
    Usmani, Nazura
    Siddiqui, Shahid Ali
    Habib, Safia
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (04) : 895 - 913
  • [28] mGluR1 as a potential therapeutic target in the treatment of triple negative breast cancer
    Speyer, Cecilia L.
    Smith, Jennifer S.
    Banda, Malathi
    Mekani, Tassia
    Gorski, David H.
    CANCER RESEARCH, 2011, 71
  • [29] Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer
    Rhodes, Lyndsay V.
    Tilghman, Syreeta L.
    Boue, Stephen M.
    Wang, Shuchun
    Khalili, Hafez
    Muir, Shannon E.
    Bratton, Melyssa R.
    Zhang, Qiang
    Wang, Guangdi
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    ONCOLOGY LETTERS, 2012, 3 (01) : 163 - 171
  • [30] The fate of chemoresistance in triple negative breast cancer (TNBC)
    O'Reilly, Elma A.
    Gubbins, Luke
    Sharma, Shiva
    Tully, Riona
    Guang, Matthew Ho Zhing
    Weiner-Gorzel, Karolina
    McCaffrey, John
    Harrison, Michele
    Furlong, Fiona
    Kell, Malcolm
    McCann, Amanda
    BBA CLINICAL, 2015, 3 : 257 - 275
12345